Publicly traded company BioSig merges with Streamex, planning to raise $1.1 billion to support RWA tokenization, with Cantor Fitzgerald leading the placement agent.

Nasdaq-listed medical device technology company BioSig Technologies has announced a merger with Streamex Exchange Corporation, another Nasdaq-listed company, and has also signed a financing agreement of up to $1.1 billion to advance the development of its $RWA tokenization business, promote the on-chaining of the $142 trillion commodity market, and focus on gold tokenization. It is reported that the company will sell $100 million worth of senior secured convertible bonds and a $1.0 billion equity line of credit. Tether asset custodian Cantor Fitzgerald is acting as the joint lead placement agent for the deal. (Businesswire) [Odaily Planet Daily]